| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008197180 |
| P356 | DOI | 10.1007/S11011-012-9364-0 |
| P8608 | Fatcat ID | release_cdxckwntgbhoxa7lxjew7eogyi |
| P698 | PubMed publication ID | 23296469 |
| P5875 | ResearchGate publication ID | 234084604 |
| P50 | author | Oliviero Riggio | Q37842061 |
| Manuela Merli | Q39067771 | ||
| Federica Moscucci | Q57011309 | ||
| P2093 | author name string | Carlo Merkel | |
| Chiara Izzo | |||
| Lorenzo Ridola | |||
| Silvia Nardelli | |||
| Chiara Pasquale | |||
| Ilaria Pentassuglio | |||
| Concetta Mina | |||
| Massimo Marianetti | |||
| Mariangela Fratino | |||
| P2860 | cites work | The MOS 36-ltem Short-Form Health Survey (SF-36) | Q26778425 |
| Neuropsychological characterization of hepatic encephalopathy | Q28204449 | ||
| Prevalence of alexithymia and its association with anxiety and depression in a sample of Greek chronic obstructive pulmonary disease (COPD) outpatients. | Q33863640 | ||
| Factors associated with poor health-related quality of life of patients with cirrhosis | Q33935013 | ||
| Self-rating depression scale in an outpatient clinic. Further validation of the SDS. | Q34052097 | ||
| Orbitofrontal volume reductions during emotion recognition in patients with major depression | Q34084297 | ||
| Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy | Q34576485 | ||
| A review of the alexithymia concept | Q40322684 | ||
| Somatic/affective symptoms, but not cognitive/affective symptoms, of depression after acute coronary syndrome are associated with 12-month all-cause mortality | Q44443915 | ||
| Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. | Q44661001 | ||
| Alexithymia in Chinese chronic obstructive pulmonary disease (COPD) patients: the prevalence and related factors of alexithymia | Q44748620 | ||
| Single photon emission computed tomography and statistical parametric mapping analysis in cirrhotic patients with and without minimal hepatic encephalopathy | Q44935196 | ||
| Evaluation of cingulate gyrus blood flow in patients with liver cirrhosis | Q46511756 | ||
| Symptoms of anxiety and depression in patients with chronic obstructive pulmonary disease | Q47397378 | ||
| The Italian SF-36 Health Survey: translation, validation and norming | Q47743666 | ||
| Predictors of psychiatric disorders in liver transplantation candidates: logistic regression models | Q47802632 | ||
| Quality of life in cirrhosis is related to potentially treatable factors | Q49013338 | ||
| Alexithymia and risk of death in middle-aged men. | Q51108713 | ||
| Determinants of health-related quality of life in patients with chronic liver diseases. | Q51942517 | ||
| Association between pretransplant psychological assessments and posttransplant psychiatric disorders in living-related transplantation. | Q51958410 | ||
| Depression in patients with cirrhosis. Impact on outcome. | Q53594216 | ||
| Determinants of quality of life in chronic liver patients | Q60629821 | ||
| Alexithymia and Health-Related Quality of Life in a General Population | Q61911096 | ||
| P433 | issue | 2 | |
| P921 | main subject | alexithymia | Q1129046 |
| quality of life | Q13100823 | ||
| P304 | page(s) | 239-243 | |
| P577 | publication date | 2013-01-08 | |
| P1433 | published in | Metabolic Brain Disease | Q15764352 |
| P1476 | title | Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients | |
| P478 | volume | 28 |
| Q37043813 | Aberrant Resting-State Functional Connectivity Density in Patients with Hepatitis B Virus-Related Cirrhosis |
| Q55282548 | Alexithymia in Gastroenterology and Hepatology: A Systematic Review. |
| Q46227940 | Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report |
| Q47912210 | Anxiety and depression are associated with long-term outcomes of hepatocellular carcinoma: A nationwide study of a cohort from Taiwan |
| Q43638031 | Anxiety and depressive disorders among patients with esophageal cancer in Taiwan: a nationwide population-based study. |
| Q52611555 | Assigning Clinical Significance and Symptom Severity Using the Zung Scales: Levels of Misclassification Arising from Confusion between Index and Raw Scores. |
| Q64104900 | Bicuculline Reduces Neuroinflammation in Hippocampus and Improves Spatial Learning and Anxiety in Hyperammonemic Rats. Role of Glutamate Receptors |
| Q36719278 | Chronic unpredictive mild stress leads to altered hepatic metabolic profile and gene expression |
| Q35498468 | Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score |
| Q48046773 | Complementary and Alternative Medicine Use in United States Adults With Liver Disease |
| Q47627834 | Coping and rehabilitation in alcoholic liver disease patients after hepatic encephalopathy--in interaction with professionals and relatives |
| Q47322597 | Cross-cultural validation of the 20-item Toronto Alexithymia Scale in Chinese adolescents. |
| Q33779392 | Diagnosis of covert hepatic encephalopathy without specialized tests |
| Q35642850 | Diagnosis of minimal hepatic encephalopathy |
| Q48058621 | Female gender and gastrointestinal symptoms, not brain-derived neurotrophic factor, are associated with depression and anxiety in cirrhosis |
| Q92460457 | Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms |
| Q64263567 | Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues |
| Q47785236 | Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients |
| Q38843237 | MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective |
| Q41204791 | Mindfulness-Based Stress Reduction Therapy Improves Patient and Caregiver-Reported Outcomes in Cirrhosis |
| Q35642834 | Minimal hepatic encephalopathy impairs quality of life. |
| Q58605439 | Nurse-led clinic for patients with liver cirrhosis-effects on health-related quality of life: study protocol of a pragmatic multicentre randomised controlled trial |
| Q53281784 | Palliative Care and Hospice Interventions in Decompensated Cirrhosis and Hepatocellular Carcinoma: A Rapid Review of Literature. |
| Q38412129 | Palliative care for patients with end-stage liver disease |
| Q48349992 | Palliative care in decompensated cirrhosis: A review |
| Q56980578 | Proton pump inhibitors are associated to minimal and overt hepatic encephalopathy and increase mortality in cirrhotics |
| Q47945856 | Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis |
| Q40494136 | Qualifying and quantifying minimal hepatic encephalopathy |
| Q38245124 | Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation |
| Q35752265 | Risk of Developing Depressive Disorders following Hepatocellular Carcinoma: A Nationwide Population-Based Study |
| Q35095535 | Risk of depressive disorder following non-alcoholic cirrhosis: a nationwide population-based study |
| Q45053969 | Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis |
| Q52351014 | The assessment and management of pain in cirrhosis. |
Search more.